0: Lately, MCT1 mRNA levels have been shown to be markedly reduced in the frontal cortex of CJD MM1 and VV2 patients [ 16].
1: The cerebral cortex together with the cerebellum is one of the most frequently affected brain regions in CJD patients [ 17, 18, 19].
